Nephros, Inc. NEPH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.01% | 36.16% | 6.87% | 22.20% | 35.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.01% | 36.16% | 6.87% | 22.20% | 35.42% |
| Cost of Revenue | 26.34% | 22.60% | 28.79% | 41.08% | 35.06% |
| Gross Profit | 12.73% | 44.04% | -5.10% | 11.56% | 35.64% |
| SG&A Expenses | 8.79% | 9.86% | 11.85% | 23.72% | 29.52% |
| Depreciation & Amortization | -14.71% | -17.14% | -25.64% | -5.88% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.08% | 15.18% | 18.65% | 32.59% | 34.36% |
| Operating Income | 59.55% | 389.11% | -82.86% | -94.32% | 52.43% |
| Income Before Tax | 50.59% | 391.87% | -74.91% | -82.97% | 85.79% |
| Income Tax Expenses | -- | 44.44% | -- | -100.00% | -- |
| Earnings from Continuing Operations | 51.93% | 405.06% | -74.91% | -82.23% | 84.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.93% | 405.06% | -74.91% | -82.23% | 84.15% |
| EBIT | 59.55% | 389.11% | -82.86% | -94.32% | 52.43% |
| EBITDA | 53.18% | 339.22% | -79.54% | -84.38% | 44.77% |
| EPS Basic | 48.11% | 392.41% | -75.10% | -82.48% | 82.76% |
| Normalized Basic EPS | 47.50% | 380.69% | -75.08% | -83.33% | 85.19% |
| EPS Diluted | 57.00% | 450.00% | -80.00% | -82.48% | 72.41% |
| Normalized Diluted EPS | 48.96% | 379.58% | -75.68% | -83.80% | 77.78% |
| Average Basic Shares Outstanding | 2.37% | 2.42% | 0.48% | 0.98% | 0.64% |
| Average Diluted Shares Outstanding | 1.48% | 2.77% | 3.53% | 6.15% | 4.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |